Electrochemical Sensing for Accurate L-Dopa Detection in Parkinson’s disease
Objective: This study aims to develop a cost-effective, portable electrochemical sensor for real-time L-dopa monitoring in PD patients, addressing the limitations of current detection techniques.…Sustained Motor Symptom Efficacy With Long-Term Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Treatment – Data From The ELEGANCE Interim Analysis
Objective: To evaluate the long-term effect on motor symptoms of advanced Parkinson’s disease (PD) following up to two years of treatment with LECIG by analysis…Medication therapy in Parkinson’s disease patients: a cross-sectional study at the University Medical Center at Ho Chi Minh City, Vietnam
Objective: To determine the rate of drugs prescribed to treat Parkinson's disease motor symptoms, the rate of the types of drug combinations, and the frequency…Impact of IPX203 (ER CD-LD) on nighttime sleep in patients with Parkinson’s disease experiencing motor fluctuations: A post hoc analysis of the RISE-PD trial
Objective: To explore the effects of IPX203 on nighttime sleep and motor states in patients with Parkinson’s disease (PD) experiencing motor fluctuations. Background: Sleep disturbances…Levodopa Effects In Swedd: Clinical And Kinematic Insights From A Case Report
Objective: To investigate the clinical and neurophysiological effects of levodopa treatment in a patient diagnosed with SWEDD. Background: A subset of patients with clinical features…Treatment Of Advanced Parkinson’s With Levodopa–Entacapone–Carbidopa Intestinal Gel – Impact On Dyskinesia
Objective: To evaluate the effect of long-term treatment with levodopa–entacapone–carbidopa intestinal gel (LECIG) infusion on daily time with dyskinesia in people with advanced Parkinson’s disease…Motor Fluctuations in Parkinsons Disease and their Correction
Objective: To evaluate the frequency of motor fluctuations in patients with Parkinson's disease and to study the effectiveness of methods modifying the course of the…The role of serotonergic mechanisms in the formation of levodopa-induced drug-induced dyskinesias in Parkinson’s disease
Objective: To study the quantitative content of serotonin and dopamine in the blood plasma of patients with Parkinson's disease and to conduct a clinical and…Safety and Effectiveness of Co-careldopa for Motor Recovery in Post-Stroke Patients: A Systematic Review
Objective: To examine the safety and efficacy of co-careldopa for motor recovery in post-stroke patients. Background: The use of co-careldopa for improving motor function in…Effect of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on motor fluctuations, dyskinesia, and sleep; subjective vs. PKG watch recordings.
Objective: To evaluate the impact of continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa on bradykinesia, dyskinesia, and sleep quality using self-reported Hauser diaries and Parkinson’s KinetiGraph…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 62
- Next Page »
